Back to search results

Individualized Imagery for Sleep, Psychosis, and Suicidality in Inpatients

This study is looking at how well individualized imagery scripts, delivered through compact EEG (electroencephalogram, a test that measures brain waves) and audio technology, can help inpatients with psychosis. The goal is to see if these personalized scripts, which focus on relaxation and safety, can improve sleep quality and reduce symptoms of psychosis and suicidality. You might be able to join if you are an adult (18 or older) with a primary diagnosis of schizophrenia spectrum disorder or a mood disorder with psychotic features, and you experience sleep problems. The study aims to determine if this approach is practical and helpful. The current status of the study is unclear, and it plans to enroll 40 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 40 participants.
What's involved
Study personnel will help you create personalized imagery scripts. You will wear earbuds and a Muse S headband to collect data.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be assessed from the start of the intervention to its end, up to 80 days after baseline.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06194344

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Recruiting
NAAges 18+InterventionalTreatment
The University of Texas Health Science Center, Houston
~40 participants
Updated 2025-07-16 on ClinicalTrials.gov
What's tested:Individualized imageryControl

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep)
Measured over from start of intervention to end of intervention (upto 80 days after baseline )
+2 more outcomes measured

Conditions

Psychosis

Explore related trials

Mood DisorderPsychosisSchizophrenia Spectrum Disorder

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Alia Warner, Ph.D. · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston
  • Jessica Badawi, Ph.D. · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Who to contact

Alia Warner, Ph.D., ABPP
[email protected]
713-486-2700
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review
capacity to consent to the study as determined by licensed psychologists ( or the primary attending psychiatrist
reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week.

Exclusion

primary substance- or medical-induced psychosis
intellectual and developmental disabilities
neurodegenerative cognitive disorders
implanted devices (e.g., Pacemakers)
on one-to-one supervision or 15-minute safety checks for suicidality or aggression
patients with roommates that are on 15-minute checks to minimize impact on study participants' awakenings

What this trial measures

  • Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep)from start of intervention to end of intervention (upto 80 days after baseline )
  • Feasibility as assessed by percentage of nights used for the duration of the intervention.from start of intervention to end of intervention (upto 80 days after baseline )
  • Feasibility as assessed by a self-report satisfaction survey, Was It Worth It questionnairepost-intervention(upto 80 days after baseline )

    The measure will consist of 7 items rated on a 5-point Likert scale ranging from Strongly Disagree (1) to Strongly Agree (5), for a maximum score of 35,higher number indicating better satisfaction